Delivery Order SPE2DB20D2104-SPE2DB23FU64G
Award Date
7/31/23
Potential Completion Date
8/1/23
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 5, 2024, with a ceiling value of $2,176.55 and a completion date of December 6, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on April 29, 2022 with a ceiling value of $1,239.33. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC is valued at up...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 1.25 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,372.26 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is September 14, 2023. This award is part of a larger...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 16, 2022 with a ceiling value of $1,459.10. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award IDC,...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a respiratory medication, to the Defense Logistics Agency (DLA). The award, valued at $2,287.89, was made to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,849.56 and a completion date of August 4, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $1,120.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order that provides SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,541.04, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 28, 2022. The contract has an ultimate completion date of September 29, 2022 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award....
This federal contract award is for the delivery of Spiriva Respimat 2.5 mcg inhalation medication, with a ceiling value of $7,669.16. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 22, 2024, with a delivery order contract type and firm fixed pricing. The contract has an ultimate completion date of August 23, 2024 and was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a significant customer of Amerisourcebergen. This...
This federal contract award is for the delivery of SPIRIVA RESPIMAT 2.5 MCG INH 4GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a firm fixed price of $2,814.86 and a completion date of May 7, 2024. This contract award is not associated with a set-aside designation, indicating it was awarded through full and open competition. The contract is a delivery...